Showing 1 - 2 results of 2 for search 'Andres Mariano Ruiz', query time: 0.02s Refine Results
  1. 1
    ELISA F29 -A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment.

    ELISA F29 -A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment. by Rocio Rivero, Mónica Inés Esteva, Erya Huang, Leylen Colmegna, Jaime Altcheh, Ulrike Grossmann, Andrés Mariano Ruiz, CHICO and CHICO SECURE Study Groups

    Published 2023-06-01
    Get full text
    Article
  2. 2
    Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus.

    Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus. by Julio Alonso-Padilla, Marcelo Abril, Belkisyolé Alarcón de Noya, Igor C Almeida, Andrea Angheben, Tania Araujo Jorge, Eric Chatelain, Monica Esteva, Joaquim Gascón, Mario J Grijalva, Felipe Guhl, Alejandro Marcel Hasslocher-Moreno, Manuel Carlos López, Alejandro Luquetti, Oscar Noya, María Jesús Pinazo, Janine M Ramsey, Isabela Ribeiro, Andres Mariano Ruiz, Alejandro G Schijman, Sergio Sosa-Estani, M Carmen Thomas, Faustino Torrico, Maan Zrein, Albert Picado

    Published 2020-04-01
    Get full text
    Article

Search Tools: